| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +40 K | 80.1% | $0.97 | +$38.6 K |
| Sells | 3 | -9.95 K | 19.9% | $1.02 | -$10.2 K |
| Net | -2 | +30 K | 60.1% | +$28.5 K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Cantex Pharmaceuticals, Inc. | 10%+ Owner | $3.34 M | Sep 14, 2021 | ||
| Fred A. Middleton | Director | $802 K | +$38.6 K | +5.06% | Jun 20, 2024 |
| Michael T. Andriole | PRESIDENT AND CEO, Director | $464 K | -$1.81 K | -0.39% | Feb 14, 2024 |
| Michael Alrutz | Svp And General Counsel | $161 K | Feb 1, 2024 | ||
| David Jakeman | Vp Of Finance And Accounting | $147 K | -$6.36 K | -4.14% | Feb 14, 2024 |
| Michelle LaSpaluto | Chief Financial Officer | $116 K | -$2.02 K | -1.72% | Feb 14, 2024 |
| Allen S. Melemed | Chief Medical Officer | $82.6 K | Feb 1, 2024 | ||
| Marc D. Kozin | Director | Jun 20, 2024 | |||
| Pratik S. Multani | Director | Jun 20, 2024 | |||
| Michael A. Sherman | Chief Executive Officer, Director | Jun 20, 2024 | |||
| Robert J. Meyer | Director | Jun 20, 2024 | |||
| Thomas J. Riga | COO and CCO | Nov 16, 2023 | |||
| Victoria Vakiener | Director | Jun 20, 2024 | |||
| Martha J. Demski | Director | Jun 20, 2024 | |||
| Lisa Lynn Decker | Director | Jun 20, 2024 | |||
| Catherine Gilliss | Director | Jun 9, 2023 | |||
| Patrick Machado | Director | Jun 9, 2023 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|